ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
Biotechnologia Acta Т. 17, No. 6, 2024
P. 45-55, Bibliography 18, Engl.
UDC: 6:578.834.1:615.28
doi: https://doi.org/10.15407/biotech17.06.045
Full text: (PDF, in English)
BIOTECHNOLOGICAL SYSTEM FOR THE SEARCH OF SUBSTANCES WITH POTENTIAL ACTIVITY AGAINST CORONAVIRUS
M.P. Smetiukh1, O.P. Trokhimenko2, S.O. Soloviov 1,2, I.V. Dziublyk2, O.A. Kamatskyi2, I.V. Savchuk2, N.A. Bobyr3
1 Igor Sikorsky Kyiv Polytechnic Institute, Kyiv, Ukraine
2 Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine
3 Bogomolets National Medical University, Kyiv, Ukraine
Aim. Development of a biotechnological system based on a non-pathogenic coronavirus strain for humans and a sensitive cell line to the selected strain aimed at identifying compounds with potential antiviral activity.
Methods. The study was conducted on the cell lines CEF, CEFs, and ВНК-21, which are sensitive to the avian infectious bronchitis virus (IBV). Cell cultivation was performed in flasks and microplates with adhesive surfaces at 37 °C in a 5% CO2 atmosphere. To detach the cells from the growth surface, a Versene solution (0.02%) was used, and for trypsinization of CEF, a trypsin solution (0.25%) was applied. Growth media for all cell cultures were prepared based on a mixture of RPMI-1640 and DMEM in a 1:1 ratio, supplemented with 5% fetal serum.
Results. The adaptation of the model virus IBV strain H120 to cultivation in ВНК-21 cell cultures was carried out using intermediate CEF and CEF cultures. In ВНК-21 cells, IBV induced a pronounced cytopathic effect and demonstrated high infectious titers, reaching 5.5 lg TCID50/mL. The use of intermediate CEF and CEF cell cultures facilitated the gradual adaptation of the virus to the new cultivation conditions due to the antigenic affinity between chicken embryo fibroblast cells and avian embryos.
Conclusions: As a result of the conducted research, the vaccine virus IBV H-120 was successfully adapted to cultivation conditions in ВНК-21 cell cultures, using primary trypsinized chicken embryo fibroblast cells as an intermediate system. The obtained system "ВНК-21 cell culture + IBV H-120," cultivated at 37 °C in a 5% CO2 atmosphere, can be recommended for use in further biotechnological and virological studies, particularly for evaluating the antiviral activity of potential drugs against coronaviruses.
Key words: coronavirus, IBV H-120, CEF, VNK-21, biotechnological system, infectious titer.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2024
Referenes
- Hickman D. L., Johnson J., Vemulapalli T. H., Crisler J. R., Shepherd R. Commonly Used Animal Models. In: Principles of Animal Research, Elsevier, 2017, pp. 117–175. doi: 10.1016/B978-0-12-802151-4.00007-4
- Zhou Z. L., Yang P., Wang X. G., Hu X. L., Zhang L., Shi W., Shi Z. L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, vol. 579(7798), pp. 270–273 https://doi.org/10.1038/s41586-020-2012-7
- Bao L., Deng W., Huang B., Gao H., Liu J., Ren L, Wei Q., Yu P., Xu Y., Qi F., Qu Y., Li F., Qi Lv, Wang W., Xue J., Gong S., Liu M., Wang G., Wang S., Song Z., Zhao L., Liu P., Zhao L., Ye F., Wang H., Zhou W., Zhu N., Zhen W., Yu H., Zhang X., Guo L., Chen L., Wang C., Wang Y., Wang X., Xiao Y., Q. Sun, H. Liu, F. Zhu, C. Ma, L. Yan, M. Yang, J. Han, W. Xu, W. Tan, X. Peng, Q. Jin, G. Wu, C. Qin. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature, 2020, vol. 583, no. 7818, pp. 830–833, doi: 10.1038/s41586-020-2312-y
- Bi Z., Hong W., Yang J., Lu S., Peng X. Animal models for SARS‐CoV‐2 infection and pathology. MedComm, 2021, 2(4): 548–568, doi: 10.1002/mco2.98
- Geller C., Varbanov M., Duval R. E. Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies. Viruses, 2012, 4(11): 3044–3068, doi: 10.3390/v4113044
- Hernandez, R., & Brown, D. T. Growth and maintenance of baby hamster kidney (BHK) cells. Current protocols in microbiology, 2010, 17(1): A-4H. doi: 10.1002/9780471729259.mca04hs17
- (2004). Laboratory biosafety manual, 3rd edition. Geneva: World Health Organization. Retrieved from http://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf?ua=1
- Otsuki K., Noro K., Yamamoto H., Tsubokura M. Studies on avian infectious bronchitis virus (IBV). Archives of Virology, 1979, 60(2): 115–122, doi: 10.1007/BF01348027
- Perlman S., Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nature Reviews Microbiology. 2009, 7(6): 439–450, doi: 10.1038/nrmicro2147
- Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology. 2016, 3(1): 237–261. doi: 10.1146/annurev-virology-110615-042301
- Semenyuta I. V., Trokhimenko O. P., Dziublyk I. V., Soloviov S. O., Trokhymchuk V. V., Bororova O. L., Hodyna D. M., Smetiukh M. P., Yakovenko O. K., Metelytsia L. O. Decamethoxin virucidal activity: in vitro and in silico studies. The Ukrainian Biochemical Journal. 2022, 94(3): 81–91, doi: 10.15407/ubj94.03.081
- Jiang Y., Cheng X., Zhao X., Yu Y., Gao M., Zhou S. The V617I substitution in avian coronavirus IBV spike protein plays a crucial role in adaptation to primary chicken kidney cells. Frontiers in Microbiology. 2020, v. 11, doi: 10.3389/fmicb.2020.604335
- Bickerton E., Maier H. J., Stevenson-Leggett P., Armesto M., Britton P. The S2 subunit of infectious bronchitis virus Beaudette is a determinant of cellular tropism. Journal of Virology. 2018, 92(19). doi: 10.1128/JVI.01044-18
- Jiang Y., Cheng X., Zhao X., Yu Y., Gao M., Zhou S. Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity. Vaccine, 2020, 38(15): 3157–3168, doi: 10.1016/j.vaccine.2020.01.001
- Auger A., Domi A., Bibbò E., Garcia A., Gerold G., Knodler L. A. Melnyk R. A. Efficient delivery of structurally diverse protein cargo into mammalian cells by a bacterial toxin. Molecular Pharmaceutics. 2015, 12(8): 2962–2971, doi: 10.1021/acs.molpharmaceut.5b00233
- Monteil V., Kwon H., Prado P., Hagelkrüys A., Wimmer R. A., Stahl M., Leopoldi A., Garreta E., Hurtado Del Pozo C., Prosper F., Romero J. P., Wirnsberger G., Zhang H., Slutsky A. S., Conder R., Montserrat N., Mirazimi A., Penninger J. M. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020, 181(4): 905-913.e7. doi: 10.1016/j.cell.2020.04.004
- Zhao B., Ni C., Gao R., Wang Y., Yang L., Wei J., Lv T., Liang J., Zhang Q., Xu W., Xie Y., Wang X., Yuan Z., Liang J., Zhang R., Lin X. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein & Cell. 2020, 11(10): 771–775, doi: 10.1007/s13238-020-00718-6
- Zhou Z., Zhao N., Shu Y., Han S., Chen B., Shu X. Effect of gastrointestinal symptoms in patients with COVID-19. Gastroenterology. 2020, 158(8): 2294–2297, doi: 10.1053/j.gastro.2020.03.020
- Varga Z., Flammer A. J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A. S., Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020, 395(10234): 1417–1418, doi: 10.1016/S0140-6736(20)30937-5
- Hernandez R., Brown D. T. Growth and maintenance of chick embryo fibroblasts (CEF). Current Protocols in Microbiology. 2010, 17(1): doi: 10.1002/9780471729259.mca04is17
- Jiang Y., Xue M., Tang M., Zhang D., Yu Y., Zhou S. Adaptation of the infectious bronchitis virus H120 vaccine strain to Vero cell lines. Veterinary Microbiology. 2023, 280, article no. 109709. doi: 10.1016/j.vetmic.2023.109709.
- Casais R., Dove B., Cavanagh D., Britton P. Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism. Journal of Virology. 2003, 77(16): 9084–9089, doi: 10.1128/JVI.77.16.9084-9089.2003
- Shen S., Liu D. X. Characterization of temperature-sensitive (ts) mutants of coronavirus infectious bronchitis virus (IBV). Advances in Experimental Medicine and Biology. 2001, v. 494: 557–562, doi: 10.1007/978-1-4615-1325-4_82